EDIT
Price
$1.61
Change
+$0.05 (+3.21%)
Updated
Apr 24 closing price
Capitalization
134.77M
5 days until earnings call
VCYT
Price
$32.14
Change
+$0.67 (+2.13%)
Updated
Apr 24 closing price
Capitalization
1.66B
12 days until earnings call
Ad is loading...

EDIT vs VCYT

Header iconEDIT vs VCYT Comparison
Open Charts EDIT vs VCYTBanner chart's image
Editas Medicine
Price$1.61
Change+$0.05 (+3.21%)
Volume$1.13M
Capitalization134.77M
Veracyte
Price$32.14
Change+$0.67 (+2.13%)
Volume$476.22K
Capitalization1.66B
EDIT vs VCYT Comparison Chart
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. VCYT commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Buy and VCYT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (EDIT: $1.61 vs. VCYT: $32.14)
Brand notoriety: EDIT and VCYT are both not notable
EDIT represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EDIT: 27% vs. VCYT: 45%
Market capitalization -- EDIT: $134.77M vs. VCYT: $1.66B
EDIT [@Biotechnology] is valued at $134.77M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, both EDIT and VCYT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 3 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 6 bearish.
  • VCYT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than VCYT.

Price Growth

EDIT (@Biotechnology) experienced а +25.78% price change this week, while VCYT (@Medical Specialties) price change was +3.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.80%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -2.09%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 30, 2025.

VCYT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+4.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than EDIT($135M). EDIT YTD gains are higher at: 26.772 vs. VCYT (-18.838). VCYT has higher annual earnings (EBITDA): -49.41M vs. EDIT (-233.11M). EDIT has more cash in the bank: 270M vs. VCYT (216M). VCYT has less debt than EDIT: VCYT (12.6M) vs EDIT (35M). VCYT has higher revenues than EDIT: VCYT (361M) vs EDIT (32.3M).
EDITVCYTEDIT / VCYT
Capitalization135M1.66B8%
EBITDA-233.11M-49.41M472%
Gain YTD26.772-18.838-142%
P/E RatioN/AN/A-
Revenue32.3M361M9%
Total Cash270M216M125%
Total Debt35M12.6M278%
FUNDAMENTALS RATINGS
EDIT vs VCYT: Fundamental Ratings
EDIT
VCYT
OUTLOOK RATING
1..100
1921
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
10084
SMR RATING
1..100
9588
PRICE GROWTH RATING
1..100
6156
P/E GROWTH RATING
1..100
10049
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (22) in the Biotechnology industry is somewhat better than the same rating for VCYT (83). This means that EDIT’s stock grew somewhat faster than VCYT’s over the last 12 months.

VCYT's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as EDIT (100). This means that VCYT’s stock grew similarly to EDIT’s over the last 12 months.

VCYT's SMR Rating (88) in the Biotechnology industry is in the same range as EDIT (95). This means that VCYT’s stock grew similarly to EDIT’s over the last 12 months.

VCYT's Price Growth Rating (56) in the Biotechnology industry is in the same range as EDIT (61). This means that VCYT’s stock grew similarly to EDIT’s over the last 12 months.

VCYT's P/E Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for EDIT (100). This means that VCYT’s stock grew somewhat faster than EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDITVCYT
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX74.87N/A
N/A
Principal Capital Appreciation Inst
GSVRX14.24N/A
N/A
Goldman Sachs Large Cap Value R
JEVRX8.82N/A
N/A
JHancock Disciplined Value Em Mkts Eq R6
WFATX36.47N/A
N/A
Allspring Index Asset Allocation Instl
WWMCX10.39N/A
N/A
Westwood Quality Midcap Institutional